Stock Photo - 20 November 2023, Baden-Württemberg, Tübingen: Alexander Zehnder, CEO of the biotechnology company Curevac, pictured at the company headquarters. Curevac develops vaccines based on mRNA technology. Photo: Bernd Weißbrod/dpa. - Tübingen/Baden-Württemberg/Germany

Stock Photo: 20 November 2023, Baden-Württemberg, Tübingen: Alexander Zehnder, CEO of the biotechnology company Curevac, pictured at the company headquarters.

Searchable keywords

Choose multiple keywords